Caffeine (1,3,7-trimethylpurine-2,6-dione): Practical Laboratory Guidance

What This Product Solves

Caffeine (SKU N2379) is a purine alkaloid offered by APExBIO for laboratory research applications focused on cell signaling, metabolic regulation, and cancer biology. Its primary mechanism as an adenosine receptor antagonist enables modulation of neuronal activity and energy metabolism pathways. This compound is particularly suited for workflows investigating cancer cell line inhibition, metabolic pathway studies, and obesity research using diet-induced obesity (DIO) mouse models (product_spec). Caffeine’s defined solubility profile and rapid onset of action make it a reliable tool for both in vitro and in vivo studies, provided that researchers adhere to product-specific handling parameters.

For further details on laboratory use parameters and solubility constraints, see the internal guide "Caffeine (1,3,7-trimethylpurine-2,6-dione): Lab Use Parameters", which outlines compatibility with various assay types and best practices for solution preparation.

Protocol Parameters

• Assay: In vitro cancer cell line inhibition
  Value: IC50 ≈ 2 mM
  Applicability: Patient-derived undifferentiated pleomorphic sarcoma (UPS) and rhabdomyosarcoma (RMS) cell lines
  Rationale: Caffeine demonstrates dose-dependent inhibition in these models, supporting its use in evaluating cell viability and cytostatic responses in cancer research.
  Source Type: product_spec
• Assay: Solubility for solution preparation
  Value: ≥25 mg/mL in water; ≥33.33 mg/mL in DMSO
  Applicability: Preparation of stock solutions for cell culture or animal administration
  Rationale: Ensures sufficient concentration for dosing without precipitation; do not use ethanol as caffeine is insoluble.
  Source Type: product_spec
• Assay: Solution stability
  Value: Use immediately after preparation; do not store long-term
  Applicability: Any workflow requiring reliable and reproducible dosing, especially for metabolic or cancer research assays
  Rationale: Caffeine solutions are unstable over extended periods, which may compromise experimental consistency.
  Source Type: product_spec
• Assay: Storage conditions (solid form)
  Value: -20°C
  Applicability: Long-term storage of raw material prior to use
  Rationale: Preserves compound integrity and prevents degradation before solution preparation.
  Source Type: product_spec

Workflow Setup and QC Checklist

• Verify compound identity: Confirm that the product received matches the chemical formula (C8H10N4O2) and molecular weight (194.19) as listed in the product dossier.
• Solubilization protocol: Dissolve caffeine in water (≥25 mg/mL) or DMSO (≥33.33 mg/mL). Avoid ethanol due to insolubility (Lab Use Guide).
• Stock solution preparation: Prepare fresh solutions immediately prior to use. Discard any unused portion to prevent variable dosing due to degradation.
• Storage: Store solid caffeine at -20°C in a sealed container with desiccant. Minimize freeze-thaw cycles.
• Cell line selection: For cancer research, select validated patient-derived UPS or RMS cell lines when evaluating inhibitory effects.
• Combination protocols: When combining with agents such as valproic acid (VPA), validate compatibility and dosing to optimize efficacy.
• Documentation: Record lot number, preparation date, and any deviations from standard protocol for traceability.

Common Failure Modes and Fixes

• Precipitation in solution: Occurs if attempting to dissolve caffeine in ethanol or exceeding solubility limits. Fix by switching to water or DMSO and ensuring concentrations do not surpass the solubility threshold.
• Loss of activity due to solution aging: Using stored caffeine solutions can result in variable results. Always prepare fresh solutions prior to use and discard leftovers.
• Variable dosing in cell-based assays: Can result from inconsistent solution preparation or compound degradation. Standardize all preparation steps and adhere to recommended stability guidelines.
• Incorrect storage temperature: May cause degradation of the solid compound. Confirm freezer settings and regularly audit storage conditions.

Scope and Limitations

Caffeine (N2379) is validated for in vitro assays involving cancer cell line inhibition and metabolic regulation, as well as for in vivo studies in diet-induced obesity mouse models. Its use should be restricted to workflows that do not require ethanol solubility or long-term solution storage; protocols necessitating these features are incompatible with the product’s properties (Practical Lab Use). The compound is not suitable for clinical or diagnostic applications and should only be used in research contexts with appropriate controls and documentation.

Researchers are advised to consult the article "Caffeine (1,3,7-trimethylpurine-2,6-dione) in Lab Research" for further discussion on mechanistic roles and application boundaries related to adenosine receptor antagonism and metabolic pathway modulation.

Conclusion

Caffeine (1,3,7-trimethylpurine-2,6-dione, SKU N2379) is a robust research tool for lab studies in cancer biology and metabolic regulation, provided that recommended handling, solubilization, and storage protocols are strictly followed. Its well-characterized action and clear boundaries make it an asset for reproducible, targeted experimental design. For full technical details and purchasing information, see the APExBIO Caffeine product page.